InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the full record of transactions filed by Engelhart James, Chief Financial Officer. Officer active across 1 companies, notably Biohaven Pharmaceutical Holding Co Ltd.. Aggregated, 6 reports have been logged. The latest transaction was filed on 6 January 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is openly available.
Declarations6 total
03,750 shares0
Common Shares
SEC:0001562180-22-000353·
03,750 shares0
Common Shares
SEC:0001562180-22-000353:0·
035,000 shares0
Common Shares
SEC:0001562180-21-007628·
035,000 shares0
Common Shares
SEC:0001562180-21-007628:0·
03,700 shares0
Common Shares
SEC:0001562180-21-007300·
03,700 shares0
Common Shares
SEC:0001562180-21-007300:0·
6 of 6 declarations
About Engelhart James
Engelhart James is the Chief Financial Officer and Strategic Advisor at Biohaven Pharmaceutical Holding Co Ltd. In this role, he oversees financial operations and contributes to the growth strategy of the company. His expertise in finance and risk management is essential for ensuring the financial health and sustainability of Biohaven.
